Bioharvest Sciences, Inc. (TSE:BHSC) has released an update.
BioHarvest Sciences Inc. has announced the issuance of 700,000 restricted share units to a consultant based on achieving revenue milestones throughout 2024, alongside 300,000 warrants to aid in the expansion of the company’s production capacity to a new facility in Israel. These financial instruments aim to incentivize consultants for their contributions to the company’s growth and operational transition. BioHarvest employs a unique botanical synthesis technology for the production of plant-based molecules used in various health and wellness products.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
